MDU Resources Group Inc. Common Stock (Holding Company) vs Novavax Inc — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while Novavax Inc trades at $12.46 (market cap $2.11B). The key difference: MDU Resources Group Inc. Common Stock (Holding Company) is the larger of the two by market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays a 3.03% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and Novavax Inc for 59 Days on average.
| MDU | NVAX | |
|---|---|---|
Market Cap | $3.92B | $2.11B |
Volume | 1,027,656 | 8,376,831 |
Sector | Utilities | Health |
52-Week High | $22.80 | $12.82 |
52-Week Low | $18.39 | $6.22 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $6.45B | $1.69B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $12.64, down slightly by 0.16% on the day. The stock shows a bullish technical signal with strong moving average and oscillator support. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of -$0.32 surpassing the -$0.38 estimate. The company is transitioning its business model toward a partnership-driven approach centered on its Matrix-M adjuvant technology, with recent regulatory approvals for its updated COVID-19 vaccine in major markets.
The outlook is mixed with strong analyst buy ratings (73.9%) and recent business developments providing catalysts, but significant financial risks remain including negative cash flows, high debt levels, and inconsistent profitability. Investment opportunity exists in the partnership strategy execution, while risks include execution challenges and competitive pressures in the vaccine market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.
Read more on MDU →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →